Should You Buy Lockheed Martin While It's Up 26% in 2026?
By Maksym Misichenko · Nasdaq ·
By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is bearish on Lockheed Martin (LMT) due to its elevated valuation, execution risks, and uncertain future margins despite a strong backlog.
Risk: The 'execution gap' and high trailing P/E of 30 without clear margin of safety for potential delays or shifts in procurement timelines.
Opportunity: None identified as a consensus opportunity.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Key Points
Lockheed Martin has consistently paid a dividend for three decades.
The company reported sales growth of 6% in the fourth quarter of 2025, and anticipates similar growth in 2026.
- 10 stocks we like better than Lockheed Martin ›
In a year marked by volatility and uncertainty, Lockheed Martin (NYSE: LMT) has been a bright spot in the market thus far. Shares of Lockheed are up over 26% in 2026, far outpacing the broader market indexes.
With Lockheed's valuation rising, is the stock still a buy?
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Lockheed's financials have been somewhat of a mixed bag, but there are several positive signs in the latest quarterly report. The company's backlog is a massive $194 billion, sales grew 6% year over year, and free cash flow exceeded expectations.
The bull case for Lockheed depends on military spending steadily increasing. The Trump administration has proposed a defense budget of up to $1.5 trillion for 2027, a marked increase from the $900 billion appropriated for 2026. This policy shift could generate a substantial number of new contracts for Lockheed.
Unfortunately, Lockheed's valuation metrics have risen to the point where the stock is teetering on the edge of overvaluation. The stock's trailing P/E ratio is nearing 30. In the past 12 months, the company's market capitalization has increased from $104 billion to $144 billion.
If you're taking a long-term view, though, the current share price shouldn't scare you away. Lockheed's guidance for 2026 maintains a sales growth rate of 5% and segment operating growth of 25%.
Lockheed's dividend yield is fairly strong at 2.2%. This stock has a lot to offer investors seeking stable growth and income, even though its recent run has made shares more expensive.
Should you buy stock in Lockheed Martin right now?
Before you buy stock in Lockheed Martin, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Lockheed Martin wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $503,268!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,049,793!*
Now, it’s worth noting Stock Advisor’s total average return is 898% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of March 27, 2026.
Catie Hogan has no position in any of the stocks mentioned. The Motley Fool recommends Lockheed Martin. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"LMT's valuation has decoupled from near-term cash generation—the stock is pricing in defense budget passage and contract wins that aren't yet certain, leaving little margin for disappointment."
LMT's 26% YTD run is real, but the article conflates two separate stories: a strong backlog ($194B) and near-term valuation risk. Trailing P/E near 30 is elevated for a defense contractor, even with 5-6% sales growth guidance. The $1.5T defense budget proposal is bullish, but it's a 2027 proposal—not law. Free cash flow beat is mentioned but no numbers given. The 2.2% yield is modest for a 'stable income' play. Most critically: the article admits Motley Fool's own analysts didn't pick LMT despite recommending it elsewhere. That's a red flag worth interrogating.
If the $1.5T budget passes and LMT wins meaningful new contracts, the backlog converts to revenue faster, justifying current multiples; a 25% segment operating growth guidance (buried in the text) suggests margin expansion that could support a 30x multiple.
"LMT's current valuation of 30x earnings is unsustainable for a company with 6% revenue growth, regardless of the projected defense budget increase."
Lockheed Martin (LMT) is trading at a dangerous disconnect from its fundamentals. A trailing P/E of 30 for a defense prime with mid-single-digit revenue growth is historically unprecedented; LMT typically trades closer to 15-18x. While the $194B backlog and a proposed $1.5T 2027 budget provide a massive floor, the article ignores the 'execution gap.' Lockheed has struggled with F-35 TR-3 software delays and margin compression in its rotary and mission systems. A 26% YTD run-up suggests the market has already priced in the 2027 budget expansion, leaving zero margin for error if procurement timelines shift or deficit hawks challenge the $1.5T figure.
If the 2027 defense budget actually hits $1.5T, LMT’s massive backlog could undergo a 're-rating' as investors treat it like a high-growth tech utility rather than a cyclical industrial. Furthermore, if geopolitical instability escalates, the 2.2% dividend yield provides a defensive floor that few other sectors can match.
"Lockheed’s strong fundamentals and massive backlog support the rally, but a near‑30x P/E and concentrated program/execution risks make the stock a cautious, selective hold unless higher confirmed defense spending and margin conversion arrive."
Lockheed’s 26% YTD surge is grounded in a huge $194B backlog, steady organic sales (6% Q4) and strong free cash flow — all sensible under a rising U.S. defense budget narrative. But the article downplays two crucial points: backlog composition (firm fixed‑price work vs options and foreign sales tied to approvals) and program concentration (F‑35, helicopters, missiles) that create execution and margin risk. Valuation has re‑rated to ~30x trailing P/E, pricing in sustained budget increases and flawless program execution. For long‑term investors this is a classic ‘good business, expensive entry’ — fine as a selective position, not a buy‑and‑forget.
If Congress and allies lock in materially higher multi‑year defense appropriations and Lockheed converts backlog into higher‑margin sustainment work and buybacks, current valuation could prove conservative and justify further upside. Also, geopolitical shocks could accelerate urgent procurements that disproportionately benefit prime contractors like LMT.
"LMT's 30x trailing P/E after 26% YTD gains prices in flawless execution on modest 5% sales growth, vulnerable to a 15-20% pullback on budget delays."
Lockheed Martin's $194B backlog offers multi-year revenue visibility, bolstered by 6% Q4 2025 sales growth and guidance for 5% in 2026 plus 25% segment operating growth. The proposed $1.5T 2027 defense budget under Trump could accelerate contracts, supporting the 2.2% dividend yield for income seekers. However, after 26% YTD gains pushing trailing P/E to ~30x and market cap to $144B, the stock embeds aggressive assumptions—modest top-line growth doesn't justify the premium versus historical 18-20x averages. FCF beat is positive, but execution risks loom if supplemental budgets falter.
If the $1.5T budget materializes and geopolitical tensions persist, LMT's prime contractor status could drive EPS surprises, expanding multiples to 35x as in prior defense upcycles.
"Backlog quality, not size, determines whether 30x P/E is justified—and the article omits the breakdown entirely."
ChatGPT nails the backlog composition risk—but nobody quantified it. LMT's $194B backlog includes foreign military sales requiring State Department approval; delays there crater conversion rates without touching U.S. budget. Also: F-35 sustainment (high-margin, recurring) versus new platform work (lumpy, competitive) aren't equal revenue. Gemini's 'execution gap' is real, but the article doesn't disclose what percentage of backlog is at-risk or delayed. That's the number that matters at 30x P/E.
"Front-loaded R&D costs for next-gen tech will likely suppress margins before the 2027 budget windfall arrives, creating a valuation air pocket."
Claude and Grok are banking on that 25% segment operating growth guidance to justify the 30x multiple, but they’re ignoring the 'R&D trap.' Lockheed is pivoting heavily into hypersonics and AI-driven electronic warfare—sectors where R&D costs are front-loaded and margins are notoriously thin during the development phase. If that 25% growth is back-weighted toward 2027, the stock faces a massive 'valuation air pocket' in 2025-2026 as legacy F-35 margins plateau.
[Unavailable]
"LMT's 25% op growth guidance already accounts for R&D costs, and near-term supplemental aid accelerates backlog conversion."
Gemini, your R&D 'trap' assumes front-loaded costs overwhelm the 25% segment op growth guidance, but that's management's forecast after modeling those investments—margins expanded despite F-35 delays last year. Bigger omission across panel: supplemental Ukraine/Israel aid ($60B+ proposed) juices LMT's munitions backlog conversion now, not waiting for 2027 budget.
The panel consensus is bearish on Lockheed Martin (LMT) due to its elevated valuation, execution risks, and uncertain future margins despite a strong backlog.
None identified as a consensus opportunity.
The 'execution gap' and high trailing P/E of 30 without clear margin of safety for potential delays or shifts in procurement timelines.